The impact of Covid 19 on the sinuses, with a logistical assessment to know the risk factors.
DOI:
https://doi.org/10.62480/tjms.2023.vol19.pp97-103Keywords:
Covid-19, sinuses, CRSwNPAbstract
Sinusitis is the inflammation of the paranasal sinuses; these are cavities that we have in the face, as well as in the head, around the nose, and inside it. When such inflammation occurs, and this affects the nasal passages.
References
Cai Q, Huang D, Ou P, et al. COVID-19 in a designated infectious diseases hospital outside Hubei province, China. Allergy. 2020; 75 (7):1742-1752.
Nikpouraghdam M, Farahani AJ, Alishiri G, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: a single center study. J Clin Virol. 2020; 127:104378.
Krajewska J, Krajewski W, Zub K, Zaton´ski T. COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Otorhinolaryngol. 2020;277 (7):1885-1897.
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature.2020;579 (7798):270-273.
Giacomelli A, Pezzati L, Conti F, et al. Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus two infections: a cross-sectional study. Clin Infect Dis. 2020;71 (15):889-890.
Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277 (8): 2251-2261.
Mullol J, Alobid I, Marin˜o-S´anchez F, et al. The loss of smell and taste in the COVID-19 outbreak: a tale of many countries. Curr Allergy Asthma Rep. 2020;20 (10):1-5.
Ueha R, Kondo K, Kagoya R, Shichino S, Yamasoba T. ACE2, TMPRSS2, and furin expression in the nose and olfactory bulb in mice and humans. Rhinology. 2021;59 (1):105-109.
Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020; 58 (suppl S29):1-464.
Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323 (15):1488-1494.
Jalessi M, Barati M, Rohani M, et al. Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19. Neurol Sci. 2020;41 (9):2331-2338.
World Health Organization. Clinical Management of Severe Acute Respiratory Infection (SARI) When COVID-19 Disease Is Suspected: Interim Guidance, 13 March 2020. World Health Organization; 2020.
Khalagi K, Gharibzadeh S, Khalili D, et al. Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 serological Surveillance program. Clin Microbiol Infect. 2021; S1198-743X (21)00298–6.
Lee SW, Kim SY, Moon SY, et al. Estimating COVID-19 infection and severity risks in patients with chronic rhinosinusitis: a Korean nationwide cohort study. J Allergy Clin Immunol Pract. 2021;9 (6):2262-2271. e2.
Wei CC, Adappa ND, Cohen NA. Use of topical nasal therapies in the management of chronic rhinosinusitis. Laryngoscope. 2013; 123 (10):2347-2359.
Klimek L, Jutel M, Bousquet J, et al. Management of patients with chronic rhinosinusitis during the COVID-19 pandemic—an EAACI position paper. Allergy. 2021;76 (3):677-688.
Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146 (1):203-206.e3.
Ferastraoaru D, Hudes G, Jerschow E, et al. Eosinophilia in asthma patients is protective against severe COVID-19 illness. J Allergy Clin Immunol. 2021;9 (3):1152-1162. e3.
Heidari F, Karimi E, Firouzifar M, et al. Anosmia as a prominent symptom of COVID-19 infection. Rhinology. 2020;58 (3): 302-303.
Speth MM, Singer-Cornelius T, Oberle M, Gengler I, Brockmeier SJ, Sedaghat AR. Olfactory dysfunction and sinonasal symptomatology in COVID-19: prevalence, severity, timing, and associated characteristics. Otolaryngol Head Neck Surg. 2020;163 (1): 114-120.
Renaud M, Leon A, Trau G, et al. Acute smell and taste loss in outpatients: all infected with SARS CoV-2. Rhinology. 2020; 58 (4):406-409.
Machado C, Gutierrez JV. Anosmia and ageusia as initial or unique symptoms after SARS-CoV-2 virus infection. Preprints. 2020.
da Costa KV, Carnauba ATL, Rocha KW, Andrade KCLd, Fer- ´ reira S, Menezes PdL. Olfactory and taste disorders in COVID-19: a systematic review. Braz J Otorhinolaryngol. 2020;86 (6):781-792.
Dejaco D, Riedl D, Huber A, et al. The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights. Eur Arch Otorhinolaryngol. 2019;276 (5):1355-1365.
Soler ZM, Jones R, Le P, et al. Sino-nasal outcome test-22 outcomes after sinus surgery: a systematic review and meta-analysis. Laryngoscope. 2018;128 (3):581-592.
Phillips KM, Hoehle LP, Gray ST, Caradonna DS, Sedaghat AR. Determinants of noticeable symptom improvement despite subMCID change in SNOT-22 score after treatment for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2018;9 (5):508-513.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
